Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study

NCT04071652 is registered in ClinicalTrials.gov with Mitralix as lead sponsor.

NCT NCT04071652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study
Lead sponsor
Mitralix
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2017
Completion date
February 28, 2023
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid valve regurgitation